Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018), 836 34-43].

Salaga, Maciej; Binienda, Agata; Tichkule, Ritesh B; Thakur, Ganesh A; Makriyannis, Alexandros; Storr, Martin; Fichna, Jakub

Salaga, Maciej; Binienda, Agata; Tichkule, Ritesh B; Thakur, Ganesh A; Makriyannis, Alexandros; Storr, Martin; Fichna, Jakub.

Afiliação

Salaga M; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Binienda A; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Tichkule RB; Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry & Chemical Biology, Northeastern University, Boston, MA, United States.
Thakur GA; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, United States.
Makriyannis A; Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry & Chemical Biology, Northeastern University, Boston, MA, United States.
Storr M; Center of Endoscopy, Starnberg, Germany and Department of Medicine 2, Ludwig-Maximilian University Munich, Munich, Germany.
Fichna J; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland. Electronic address: jakub.fichna@umed.lodz.pl.

Eur J Pharmacol ; 862: 172656, 2019 Nov 05.

Article em En | MEDLINE | ID: mdl-31519354

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google